Lifetime opiate exposure as an independent and interactive cardiovascular risk factor in males: a cross-sectional clinical study

References

• GottshcalkLAMcGuireFLHeiserJFDinovoECBirchHDrug Abuse Deaths In Nine Cities: A Survey ReportRockvilleNational Institute of Drug Abuse1979
   Google Scholar
• CamiJFarreMDrug addictionN Engl J Med20033491097598612954747
   PubMed Web of Science ®Google Scholar
• DarkeSDegenhardtLMattickRMortality Amongst Illicit Drug Users: Epidemiology, Causes And InterventionSydneyCambridge University Press2006
   Google Scholar
• DarkeSDuflouJTorokMThe comparative toxicology and major organ pathology of fatal methadone and heroin toxicity casesDrug Alcohol Depend201010611619720472
   PubMed Web of Science ®Google Scholar
• DarkeSKayeSDuflouJSystemic disease among cases of fatal opioid toxicityAddiction200610191299130516911729
   PubMed Web of Science ®Google Scholar
• HulseGWhiteJCapeGManagement of Drug and Alcohol ProblemsSydneyOxford University Press2002
   Google Scholar
• Oviedo-JoekesEBrissetteSMarshDCDiacetylmorphine versus methadone for the treatment of opioid addictionN Engl J Med2009361877778619692689
   PubMed Web of Science ®Google Scholar
• McLaughlinPJZagonISWhiteWJPerinatal methadone exposure in rats. Effects on body and organ developmentBiol Neonate1978341–24854698324
   PubMedGoogle Scholar
• ZagonISVerderameMFMcLaughlinPJThe biology of the opioid growth factor receptor (OGFr)Brain Res Brain Res Rev200238335137611890982
   PubMedGoogle Scholar
• ChengFMcLaughlinPJVerderameMFZagonISThe OGF-OGFr axis utilizes the p16INK4a and p21 WAF1/CIP1 pathways to restrict normal cell proliferationMol Biol Cell200920131932718923142
   PubMed Web of Science ®Google Scholar
• FeeroWGGuttmacherAEMcCarthyMIGenomics, type 2 diabetes, and obesityN Engl J Med2010363242339235021142536
   PubMed Web of Science ®Google Scholar
• O’DonnellCJNabelEGGenomics of cardiovascular diseaseN Engl J Med2011365222098210922129254
   PubMed Web of Science ®Google Scholar
• ViselAZhuYMayDTargeted deletion of the 9p21 non-coding coronary artery disease risk interval in miceNature2010464728740941220173736
   PubMed Web of Science ®Google Scholar
• HarismendyONotaniDSongX9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling responseNature2011470733326426821307941
   PubMed Web of Science ®Google Scholar
• PasmantESabbaghAVidaudMBiecheIANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWASFASEB J201025244444820956613
   PubMed Web of Science ®Google Scholar
• JamisonRNSerraillierJMichnaEAssessment and treatment of abuse risk in opioid prescribing for chronic painPain Res Treat2011201194180822110936
   PubMedGoogle Scholar
• US Department of Health and Human Services, Substance Abuse And Mental Health Services Administration, Office of Applied StudiesDrug Abuse Warning Network (DAWN), Treatment Episode Data Set – Admissions (Teds-A) – Concatenated, 1992 to 2009 [Computer file] Prepared by Synectics for Management Decisions, Incorporated. ICPSR25221-v420111 Available from http://www.samhsa.gov/data/DASIS.aspx?qr=t#TEDSAccessed December 28, 2011
   Google Scholar
• VerbekeFMarechalCVan LaeckeSAortic stiffness and central wave reflections predict outcome in renal transplant recipientsHypertension201158583383821896935
   PubMed Web of Science ®Google Scholar
• Van BortelLMDuprezDStarmans-KoolMJClinical applications of arterial stiffness, Task Force III: recommendations for user proceduresAm J Hypertens200215544545212022247
   PubMed Web of Science ®Google Scholar
• NicholsWWClinical measurement of arterial stiffness obtained from noninvasive pressure waveformsAm J Hypertens2005181 Pt 23S10S15683725
   PubMed Web of Science ®Google Scholar
• NicholsWWMcDonald’s Blood Flow in Arteries: Theoretical, Experimental and Clinical PrinciplesNicholsWWO’RourkeMFLondonHodder Arnold2005
   Google Scholar
• ChienKRKarsentyGLongevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and boneCell2005120453354415734685
   PubMed Web of Science ®Google Scholar
• Opiate exposure increases arterial stiffness, advances vascular age and is an independent cardiovascular risk ractor in females: a cross-sectional clinical studyWorld J Cardiovascular Diseases
   Google Scholar
• ReeceASHulseGKImpact of opioid pharmacotherapy on arterial stiffness and vascular ageing: cross-sectional and longitudinal studiesCardiovasc Toxicol Epub332013
   Web of Science ®Google Scholar
• ReeceASHulseGKReduction in arterial stiffness and vascular age by naltrexone-induced interruption of opiate agonismBMJ Open201333e002610
   PubMed Web of Science ®Google Scholar
• ReeceASPsychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant programSubst Abuse Treat Prev Policy200723518036213
   PubMed Web of Science ®Google Scholar
• ReeceASEvidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkersImmun Ageing20074617892544
   PubMedGoogle Scholar
• HserYIGelbergLHoffmanVGrellaCEMcCarthyWAnglinMDHealth conditions among aging narcotics addicts: medical examination resultsJ Behav Med200427660762215669446
   PubMed Web of Science ®Google Scholar
• RandallDDegenhardtLVajdicCMIncreasing cancer mortality among opioid-dependent persons in Australia: a new public health challenge for a disadvantaged populationAust N Z J Public Health201135322022521627721
   PubMed Web of Science ®Google Scholar
• ReeceASHypothalamic opioid-melanocortin appetitive balance and addictive cravingMed Hypotheses201176113213720926200
   PubMed Web of Science ®Google Scholar
• RosenDSmithMLReynoldsCF3rdThe prevalence of mental and physical health disorders among older methadone patientsAm J Geriatr Psychiatry200816648849718515693
   PubMed Web of Science ®Google Scholar
• SadeghianSDarvishSDavoodiGThe association of opium with coronary artery diseaseEur J Cardiovasc Prev Rehabil200714571571717925633
   PubMedGoogle Scholar
• DegenhardtLRandallDHallWLawMButlerTBurnsLMortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives savedDrug Alcohol Depend20091051–291519608355
   PubMed Web of Science ®Google Scholar
• ReeceASDavidsonPDeficit of circulating stem – progenitor cells in opiate addiction: a pilot studySubst Abuse Treat Prev Policy200721917615060
   PubMed Web of Science ®Google Scholar
• RussoSJBolanosCATheobaldDEIRS2-Akt pathway in mid-brain dopamine neurons regulates behavioral and cellular responses to opiatesNat Neurosci2007101939917143271
   PubMed Web of Science ®Google Scholar
• CoppeJPRodierFPatilCKFreundADesprezPYCampisiJTumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotypeJ Biol Chem201128642363963640321880712
   PubMed Web of Science ®Google Scholar
• Cunha-OliveiraTRegoACGarridoJBorgesFMacedoTOliveiraCRStreet heroin induces mitochondrial dysfunction and apoptosis in rat cortical neuronsJ Neurochem2007101254355417250679
   PubMed Web of Science ®Google Scholar
• HutchinsonMRZhangYShridharMEvidence that opioids may have toll-like receptor 4 and MD-2 effectsBrain Behav Immun2010241839519679181
   PubMed Web of Science ®Google Scholar
• AndersonJEA role for nitric oxide in muscle repair: nitric oxidemediated activation of muscle satellite cellsMol Biol Cell20001151859187410793157
   PubMed Web of Science ®Google Scholar
• BhaumikDScottGKSchokrpurSMicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8Aging (Albany NY)20091440241120148189
   PubMedGoogle Scholar
• ReeceASDentition of addiction in Queensland: poor dental status and major contributing drugsAust Dent J200752214414917687962
   PubMed Web of Science ®Google Scholar
• ReeceASHair graying in substance addictionArch Dermatol2007143111611817224556
   PubMedGoogle Scholar
• KimTWAlfordDPMalabananAHolickMFSametJHLow bone density in patients receiving methadone maintenance treatmentDrug Alcohol Depend200685325826216860495
   PubMed Web of Science ®Google Scholar